60 Degrees Pharmaceuticals LLC
5 clinical trials · Sponsor
◉ Watch 60 Degrees Pharmaceuticals LLC
| Record | Firm | Date |
|---|---|---|
| B-FREE Chronic Babesiosis Study (NCT06656351) | 60 Degrees Pharmaceuticals LLC | 2025-11-18 |
| Oral Tafenoquine Plus Standard of Care Versus Placebo Plus Standard of Care for Babesiosis (NCT06207370) | 60 Degrees Pharmaceuticals LLC | 2024-06-17 |
| Tafenoquine in Patients With Mild to Moderate COVID-19 (NCT04533347) | 60 Degrees Pharmaceuticals LLC | 2021-02-19 |
| Long-Term Safety Study of Tafenoquine (NCT03320174) | 60 Degrees Pharmaceuticals LLC | 2017-10-05 |
Track 60 Degrees Pharmaceuticals LLC automatically
Every clearance here is in the API, with alerts when new ones post.